We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The approval “is an important advance for [asthma] patients as it allows them to benefit from triple therapy by using one inhaler once a day,” said GSK’s Chief Scientific Officer Hal Barron. Read More
The company plans to begin commercial sales of the products by the end of the year and is offering a free starter kit of composites to dentists. Read More
Nerivio’s smartphone app helps keep track of migraine episodes and offers analytics that can be shared with healthcare professionals to monitor and inform treatment. Read More
Undetected high levels of biotin in blood samples may cause false positive or negative results in certain clinical tests that are susceptible to biotin interference, the company said. Read More
The test “offers an alternative to lab-developed tests or analyte-specific reagent combinations, potentially minimizing variability and complexity in testing,” Roche said. Read More
The pilot study will evaluate the drug’s effect on outcomes including facilitation of infection recovery, the improvement of clinical status, and the reduction in supplemental oxygen use and progression to mechanical ventilation. Read More
“The new technologies being funded … have the potential to transform the diagnostics landscape if their promise is proven in clinical studies,” said HHS Assistant Secretary for Health Brett Giroir. Read More